Similar Search Results

Imitation, patent protection and welfare

Mukherjee, Arijit (contributor); … - 2003 - [Elektronische Ressource]

Persistent link: https://www.econbiz.de/10001753043

University patents, R&D competition, and social welfare

Mazzoleni, Roberto - In: Economics of innovation and new technology 14 (2005) 6, pp. 499-515

Persistent link: https://www.econbiz.de/10002848799

Imitation, patent protection, and welfare

Mukherjee, Arijit; Pennings, Enrico - In: Oxford economic papers 56 (2004) 4, pp. 715-733

Persistent link: https://www.econbiz.de/10002349719

Pricing patents for licensing in standard-setting organizations : making sense of FRAND commitments

Layne-Farrar, Anne; Padilla, Atilano Jorge; … - In: Antitrust law journal 74 (2007) 3, pp. 671-706

Persistent link: https://www.econbiz.de/10003829832

Technology licensing under convex costs

Mukherjee, Arijit - 2010

Persistent link: https://www.econbiz.de/10003963216

How licensing resolves hold-up : evidence from a dynamic panel data model with unobserved heterogeneity

Siebert, Ralph; Graevenitz, Georg von - 2005

Persistent link: https://www.econbiz.de/10003284885

Markets versus contests for the provision of information goods

Kolmar, Martin - In: Scientific competition, (pp. 127-150). 2008

Persistent link: https://www.econbiz.de/10003724976

Pricing patents for licensing in standard setting organisation : making sense of FRAND commitments

Layne-Farrar, Anna; Padilla, Atilano Jorge; … - 2007

Persistent link: https://www.econbiz.de/10003413532

Pricing patents for licensing in standard setting organizations : making sense of FRAND commitments

Layne-Farrar, Anne (contributor); … - 2007

Persistent link: https://www.econbiz.de/10003571974

The Welfare Implications of Patent Protection, Pricing, and Licensing in the Indian Oral Anti-Diabetic Drug Market

Chatterjee, Chirantan - 2015

We evaluate the welfare effects of differential pricing, voluntary licensing, and compulsory licensing in the Indian market for oral anti-diabetic (OAD) drugs. This market includes a new class of molecules called DPP-4 inhibitors, all of which are under patent protection in India. The Indian...

Persistent link: https://www.econbiz.de/10013035611